# Athos Therapeutics

> Athos Therapeutics is a VC fund backing Health Care and Biotechnology. See 1 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Torrance, United States
- Total investments: 1
- Last investment: May 2023
- Lead investor: 0%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/athostx/
- X (Twitter): https://twitter.com/athostx
- Website: https://athostx.com/

Athos Therapeutics is a late pre-clinical stage biotechnology company pioneering the development of artificial intelligence-based Precision Therapeutics for patients with Inflammatory Bowel, other Autoimmune Diseases, and cancer.

## Contacts

5 contacts available for Athos Therapeutics. Shizune tracks 2 team members at Athos Therapeutics. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/athos-therapeutics?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 1 | 100% |
| Biotechnology | 1 | 100% |
| Medical Device | 1 | 100% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Allan J. Pantuck | Co-Founder, and Chief Medical Officer | 0 | — |
| Dimitrios Iliopoulos | CEO, President | 0 | — |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| RedDress | RedDress is a medical device company that developed a wound care product that helps the human body on the wound healing process. It specializes in wound care, wound healing, tissue repair, regenerative medicine, chronic ulcers, diabetic and foot ulcers. The company was founded in 2009 and headquartered in Tel Aviv, Israel. | $26M | Series D | May 24, 2023 |  |

1 of 1 investments shown.

## Co-investors
- [HCS Capital](https://shizune.co/investors/profile/hcs-capital-partners) — VC Fund, 1 deal together
- Ragnar — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Sigma Partners](https://shizune.co/investors/profile/sigma-partners) — VC Fund
- [EDBI](https://shizune.co/investors/profile/edbi) — VC Fund
- [Trifecta Capital Advisors](https://shizune.co/investors/profile/trifecta-capital-advisors) — VC Fund

## FAQ

### What does Athos Therapeutics invest in?

Athos Therapeutics invests primarily in Health Care, Biotechnology and Medical Device startups, most often at Series D stage. Most of the 1 investments tracked by Shizune back companies in Israel. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Athos Therapeutics?

Public channels for Athos Therapeutics include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Athos Therapeutics?

The team at Athos Therapeutics includes Allan J. Pantuck (Co-Founder, and Chief Medical Officer) and Dimitrios Iliopoulos (CEO, President). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co